Aerie Pharmaceuticals Inc

JPMORGAN CHASE & CO

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

562,108

Value ($000)

8,504

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	8,504	0.0%	562,108	9/30/2022
2022 Q2	8/11/2022	205	0.0%	27,354	6/30/2022
2022 Q1	5/11/2022	236	0.0%	25,901	3/31/2022
2021 Q4	2/11/2022	146	0.0%	20,812	12/31/2021
2021 Q3	11/12/2021	344	0.0%	30,105	9/30/2021
2021 Q2	8/12/2021	470	0.0%	29,400	6/30/2021
2021 Q1	5/12/2021	434	0.0%	24,274	3/31/2021
2020 Q4	2/19/2021	224	0.0%	16,604	12/31/2020
2020 Q3	11/12/2020	156	0.0%	13,676	9/30/2020
2020 Q2	8/11/2020	183	0.0%	12,428	6/30/2020
2020 Q1	5/12/2020	188	0.0%	13,920	3/31/2020
2019 Q4	2/11/2020	1,936	0.0%	80,124	12/31/2019